Literature DB >> 21382159

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites.

Thomas Sersté1, Frédéric Bert, Véronique Leflon-Guibout, Chantal Chauvet, Estelle Marcon, Tarik Asselah, Claire Francoz, François Durand, Didier Lebrec, Dominique Valla, Richard Moreau, Marie-Hélène Nicolas-Chanoine.   

Abstract

BACKGROUND AND AIMS: Bacterial DNA (bactDNA) has been found in serum and ascitic fluid (AF) of 30-40% of hospitalized patients with cirrhosis and non-neutrocytic ascites, but its prevalence in outpatients is unknown. The aim of this prospective study was to investigate the presence of bactDNA in AF and serum among cirrhotic outpatients with non-neutrocytic ascites.
METHODS: Thirty-one consecutive patients with cirrhosis and non-neutrocytic ascites, who underwent therapeutic paracentesis in our outpatient clinic, were enrolled over a 13-week period. Of these patients, 13 had a single paracentesis and 18 patients had several consecutive paracenteses (2-10) over the study period. Overall, 98 serum and non-neutrocytic AF specimens were obtained and tested for the presence of bactDNA by polymerase chain reaction amplification of the 16S ribosomal RNA gene.
RESULTS: The main causes of cirrhosis were alcohol (53.5%) and hepatitis C (30%). The median MELD score was 16 and there were 54.8% Child-Pugh C patients. BactDNA was negative in all samples from 28 of the 31 patients, including 15 patients with several paracentesis. One patient had a single AF sample culture positive and bactDNA positive for Streptococcus mitis, whereas the simultaneous blood sample was negative. For each of the last two patients, DNA from Lactococcus lactis was detected in a single blood sample but not in the simultaneous AF sample.
CONCLUSIONS: In contrast to that reported previously in hospitalized patients, bactDNA is rarely detected in serum and AF of outpatients with cirrhosis and non-neutrocytic ascites.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382159     DOI: 10.1111/j.1478-3231.2011.02448.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

Review 1.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

2.  Identification of bacterial pathogens in ascitic fluids from patients with suspected spontaneous bacterial peritonitis by use of broad-range PCR (16S PCR) coupled with high-resolution melt analysis.

Authors:  Justin Hardick; Helen Won; Kevin Jeng; Yu-Hsiang Hsieh; Charlotte A Gaydos; Richard E Rothman; Samuel Yang
Journal:  J Clin Microbiol       Date:  2012-05-09       Impact factor: 5.948

Review 3.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 4.  Bacterial translocation markers in liver cirrhosis.

Authors:  Alexandra Alexopoulou; Danai Agiasotelli; Larisa E Vasilieva; Spyros P Dourakis
Journal:  Ann Gastroenterol       Date:  2017-07-25

5.  Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study.

Authors:  Christos Triantos; Maria Kalafateli; Panagiota I Spantidea; Dimitrios Goukos; Efstratios Koutroumpakis; Christos Konstantakis; Stelios F Assimakopoulos; Charalambos Gogos; Athanasia Mouzaki; Georgios Daikos; Konstantinos Thomopoulos
Journal:  Ann Gastroenterol       Date:  2017-04-06

Review 6.  Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure.

Authors:  Cornelius Engelmann; Thomas Berg
Journal:  Visc Med       Date:  2018-07-27

7.  Alteration of the serum microbiome composition in cirrhotic patients with ascites.

Authors:  Alba Santiago; Marta Pozuelo; Maria Poca; Cristina Gely; Juan Camilo Nieto; Xavier Torras; Eva Román; David Campos; Guillaume Sarrabayrouse; Silvia Vidal; Edilmar Alvarado-Tapias; Francisco Guarner; German Soriano; Chaysavanh Manichanh; Carlos Guarner
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.